Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mizuho

5.51
+0.01000.18%
Post-market: 5.49-0.0200-0.36%16:06 EDT
Volume:3.19M
Turnover:17.62M
Market Cap:69.02B
PE:11.78
High:5.57
Open:5.53
Low:5.50
Close:5.50
Loading ...

IQVIA Holdings Is Maintained at Outperform by Mizuho

Dow Jones
·
15 May

UGI Is Maintained at Outperform by Mizuho

Dow Jones
·
15 May

NJ Resources Is Maintained at Neutral by Mizuho

Dow Jones
·
15 May

Rubrik Cut to Neutral From Outperform by Mizuho

Dow Jones
·
15 May

Sector Update: Financial Stocks Lean Lower Premarket Thursday

MT Newswires Live
·
15 May

Mizuho Financial Gr Q4 EPS $0.02 Misses $2.51 Estimate, Sales $12.83B Miss $671.67B Estimate

Benzinga
·
15 May

Mizuho Raises Price Target on Harmony Biosciences to $48 From $44, Keeps Outperform Rating

MT Newswires Live
·
15 May

Mizuho Adjusts Price Target on IQVIA Holdings to $190 From $210, Maintains Outperform Rating

MT Newswires Live
·
15 May

Mizuho Adjusts Price Target on Salesforce to $380 From $425, Maintains Outperform Rating

MT Newswires Live
·
15 May

Mizuho Downgrades CrowdStrike Holdings to Neutral From Outperform, Price Target is $425

MT Newswires Live
·
15 May

Mizuho Financial's Fiscal 2024 Profit, Ordinary Income Rise

MT Newswires Live
·
15 May

Amylyx Pharmaceuticals Is Maintained at Outperform by Mizuho

Dow Jones
·
14 May

Mizuho Adjusts Price Target on Amylyx Pharmaceuticals to $8 From $7, Maintains Outperform Rating

MT Newswires Live
·
14 May

Fortrea price target lowered to $8 from $10 at Mizuho

TIPRANKS
·
14 May

Mizuho Leasing Sees FY Net Y43.00B

Dow Jones
·
14 May

Civitas Resources Is Maintained at Outperform by Mizuho

Dow Jones
·
13 May

Exxon Mobil Is Maintained at Neutral by Mizuho

Dow Jones
·
13 May

Kosmos Energy Is Maintained at Neutral by Mizuho

Dow Jones
·
13 May

Mizuho Securities Adjusts Apellis Pharmaceuticals Price Target to $20 From $30, Maintains Neutral Rating

MT Newswires Live
·
13 May

Murphy Oil Cut to Neutral From Outperform by Mizuho

Dow Jones
·
13 May